Wilmington, DE, United States of America

Zhongjiang Jia

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Wilmington Pharmatech. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhongjiang Jia. Retrieved from https://idiyas.com/inventor/zhongjiang-jia-p0gn885b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhongjiang Jia: Innovator in FGFR Inhibition

Introduction

Zhongjiang Jia is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His work is essential in advancing medical treatments and therapies.

Latest Patents

Zhongjiang Jia holds a patent for "Salts of an FGFR Inhibitor." This innovation showcases his expertise and commitment to improving healthcare solutions. The patent reflects his dedication to addressing critical medical needs.

Career Highlights

Zhongjiang Jia is currently employed at Wilmington Pharmatech, where he continues to push the boundaries of pharmaceutical research. His role at the company allows him to collaborate with other talented professionals in the industry.

Collaborations

Zhongjiang has worked alongside colleagues such as Qun Li and Jiacheng Zhou. Their combined efforts contribute to the innovative environment at Wilmington Pharmatech.

Conclusion

Zhongjiang Jia is a prominent figure in the field of FGFR inhibition, with a patent that underscores his innovative spirit. His work at Wilmington Pharmatech and collaborations with fellow researchers highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…